ARCHIVES

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

This article is from The Cancer Letter archive.

Vol. 23 No. 45 | November 23, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Designates Zometa For Priority Review.

November 30, 2001

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

Albino African Skin Cancer Study To Be Reevaluated

April 11, 1980

Appropriations 2014: Obama Plan Good News for NIH, Bad News For Some Oncologists

April 12, 2013

NCI-Approved CTEP Trials For the Month of November

November 30, 2012

Obituary: Piotr Kulesza, 46, Pathologist At Northwestern, ECOG-ACRIN, Dies in Fall After Group Meeting

November 22, 2013